Status:
COMPLETED
IL-38 Evaluation as a Biomarker in Pediatric Asthma
Lead Sponsor:
Cairo University
Conditions:
Bronchial Asthma
Eligibility:
All Genders
6-14 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the dia...
Eligibility Criteria
Inclusion
- patients fulfilled the criteria of the Global Initiative for Asthma (GINA)
- Age group:6-14 years
Exclusion
- Malignancy
- Chronic inflammatory diseases
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT05366491
Start Date
August 1 2020
End Date
April 15 2021
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asmaa Kamal
Cairo, Egypt, 11562